Cargando…

Provider costs for prevention and treatment of cardiovascular and related conditions in low- and middle-income countries: a systematic review

BACKGROUND: The burden of cardiovascular disease (CVD) and CVD risk conditions is rapidly increasing in low- and middle-income countries, where health systems are generally ill-equipped to manage chronic disease. Policy makers need an understanding of the magnitude and drivers of the costs of cardio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brouwer, Elizabeth D., Watkins, David, Olson, Zachary, Goett, Jane, Nugent, Rachel, Levin, Carol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660724/ https://www.ncbi.nlm.nih.gov/pubmed/26612044 http://dx.doi.org/10.1186/s12889-015-2538-z

Ejemplares similares

Ranking 93 health interventions for low- and middle-income countries by cost-effectiveness
por: Horton, Susan, et al.
Publicado: (2017)

The cost-effectiveness of hypertension management in low-income and middle-income countries: a review
por: Kostova, Deliana, et al.
Publicado: (2020)

The Cost-Effectiveness of Hyperlipidemia Medication in Low- and Middle-Income Countries: A Review
por: Husain, Muhammad Jami, et al.
Publicado: (2022)

Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries
por: Levin, Ann, et al.
Publicado: (2023)

Costs of Introducing and Delivering HPV Vaccines in Low and Lower Middle Income Countries: Inputs for GAVI Policy on Introduction Grant Support to Countries
por: Levin, Ann, et al.
Publicado: (2014)

Cost effective interventions for the prevention of cardiovascular disease in low and middle income countries: a systematic review
por: Shroufi, Amir, et al.
Publicado: (2013)

Models of lifelong care for children and adolescents with chronic conditions in low-income and middle-income countries: a scoping review
por: Reif, Lindsey K, et al.
Publicado: (2022)

Cardiovascular disease and impoverishment averted due to a salt reduction policy in South Africa: an extended cost-effectiveness analysis
por: Watkins, David A, et al.
Publicado: (2016)

Cost-effectiveness of club-foot treatment in low-income and middle-income countries by the Ponseti method
por: Grimes, Caris E, et al.
Publicado: (2016)

The cost of maternal health services in low-income and middle-income countries from a provider’s perspective: a systematic review
por: Banke-Thomas, Aduragbemi, et al.
Publicado: (2020)

Dispelling the myths of providing dialysis in low- and middle-income countries
por: Teerawattananon, Yot, et al.
Publicado: (2020)

Prevalence of cardiovascular risk factors in a middle-income country and estimated cost of a treatment strategy
por: Bovet, Pascal, et al.
Publicado: (2006)

Securing accelerated access to long‐acting injectable cabotegravir for HIV prevention in low‐ and middle‐income countries
por: Jenkins, Sarah Y., et al.
Publicado: (2023)

Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models
por: Jit, Mark, et al.
Publicado: (2011)

Health service readiness to provide care for HIV and cardiovascular disease risk factors in low- and middle-income countries
por: Cockburn, Neil, et al.
Publicado: (2023)

The Impact and Cost of Scaling up Midwifery and Obstetrics in 58 Low- and Middle-Income Countries
por: Bartlett, Linda, et al.
Publicado: (2014)

The effectiveness of training strategies to improve healthcare provider practices in low-income and middle-income countries
por: Rowe, Alexander K, et al.
Publicado: (2021)

Cost and cost-effectiveness of childhood cancer treatment in low-income and middle-income countries: a systematic review
por: Fung, Alastair, et al.
Publicado: (2019)

Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries
por: Chow, Clara Kayei, et al.
Publicado: (2020)

Patient-reported outcomes for diabetes and hypertension care in low- and middle-income countries: A scoping review
por: Masyuko, Sarah, et al.
Publicado: (2021)

Selection of essential medicines for the prevention and treatment of cardiovascular diseases in low and middle income countries
por: Bazargani, Y. T., et al.
Publicado: (2018)

Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analysts
por: Jit, Mark, et al.
Publicado: (2013)

Cost-effectiveness of neonatal surgery for congenital anomalies in low-income and middle-income countries: a systematic review protocol
por: Kim, Na Eun, et al.
Publicado: (2020)

Economic Costs of Childhood Lead Exposure in Low- and Middle-Income Countries
por: Attina, Teresa M., et al.
Publicado: (2013)

The cost of dialysis in low and middle-income countries: a systematic review
por: Mushi, Lawrencia, et al.
Publicado: (2015)

Cancer Prevention in Low- and Middle-Income Countries
por: Dey, Subhojit, et al.
Publicado: (2017)

Public stewardship of private for‐profit healthcare providers in low‐ and middle‐income countries
por: Wiysonge, Charles S, et al.
Publicado: (2016)

The informal healthcare providers and universal health coverage in low and middle-income countries
por: Kumah, Emmanuel
Publicado: (2022)

Resources Required for Cervical Cancer Prevention in Low- and Middle-Income Countries
por: Campos, Nicole G., et al.
Publicado: (2016)

Cost-Effectiveness of Population Screening Programs for Cardiovascular Diseases and Diabetes in Low- and Middle-Income Countries: A Systematic Review
por: Sharma, Manushi, et al.
Publicado: (2022)

‘Implementability’ matters: using implementation research steps to guide and support non-communicable disease national planning in low-income and middle-income countries
por: Jackson-Morris, Angela Mary, et al.
Publicado: (2022)

How much does it cost to scale up surgical systems in low-income and middle-income countries?
por: Jumbam, Desmond T., et al.
Publicado: (2019)

Integrated malaria prevention in low- and middle-income countries: a systematic review
por: Musoke, David, et al.
Publicado: (2023)

Cost-effectiveness analysis of interventions for migraine in four low- and middle-income countries
por: Linde, Mattias, et al.
Publicado: (2015)

The costs of diabetes treatment in low- and middle-income countries: a systematic review
por: Moucheraud, Corrina, et al.
Publicado: (2019)

Methodology to Forecast Volume and Cost of Cancer Drugs in Low- and Middle-Income Countries
por: Martei, Yehoda M., et al.
Publicado: (2018)

Cost Effectiveness of Environmental Lead Risk Mitigation in Low‐ and Middle‐Income Countries
por: Ericson, Bret, et al.
Publicado: (2018)

Economic costs of childhood stunting to the private sector in low- and middle-income countries
por: Akseer, Nadia, et al.
Publicado: (2022)

Screening for breast cancer: Cost-effective solutions for low- & middle-income countries
por: Mishra, Gauravi A., et al.
Publicado: (2021)

Cost-Effectiveness Analysis of COVID-19 Vaccination in Low- and Middle-Income Countries
por: Utami, Auliasari M, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m90qhlq43lnd8bkjvuohtbbiuv